Cognition Therapeutics furnishes investor presentation on amyloid beta oligomer approach

COGNITION THERAPEUTICS INC

Presentation titled 'Targeting Amyloid Beta Oligomers: A Disruptive Approach to the Treatment of CNS Disorders' dated September 2024 made available.
No specific financial results, clinical data, or guidance changes disclosed in filing or exhibit.
Presentation furnished for Regulation FD; not incorporated by reference into SEC filings.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.